Access cutting-edge chronic migraine treatment through this clinical trial at a research site in Huntsville. Study-provided care at no cost to qualified participants.
Access chronic migraine specialists in Huntsville at no cost
This study follows strict safety protocols and ethical guidelines
All study-related chronic migraine treatment provided free
Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms. The goals of the study are to evaluate adverse events and how well treatment of atogepant works compared to placebo (looks like the study treatment but contains no medicine) in preventing chronic migraine in participants between 12 and 17 years of age. Atogepant
Sponsor: AbbVie
Check if you qualify for this chronic migraine clinical trial in Huntsville, AL
If you're searching for chronic migraine treatment options in Huntsville, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Huntsville research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic migraine specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.